Description
PNH
Immunophenotyping PNH Panel
PNH
TAT:
Specimen Type:
Flowcytometry Panel Test
Other Tests
-
269%
T-ALL Monitoring Minimal Residual Disease(MRD) Detection by Flow Cytometry
T ALL minimal residual disease
T-ALL Monitoring Minimal Residual Disease(MRD) Detection by Flow Cytometry
T ALL minimal residual disease
-
90%
Acute Lymphoblastic Leukemia (ALL) Panel by PCR
E2A-PBX1; TEL-AML1; MLL-AF4; MLL-ENL; MLL-AF9; BCR-ABL1 (Major,Minor/Micro)
Acute Lymphoblastic Leukemia (ALL) Panel by PCR
E2A-PBX1; TEL-AML1; MLL-AF4; MLL-ENL; MLL-AF9; BCR-ABL1 (Major,Minor/Micro)
-
259%
HLA B27 by PCR
NIL
-
231%
CD 34
CD34+ cell quantification is necessary to determine the optimal timing and to confirm the adequacy of Peripheral Blood Stem Cell (PBSC) harvests. This assay also helps to determine when to perform Bone marrow stem cell transplants; whether to continue Apheresis and to assess bone marrow and Cord blood viability. CD34+ absolute count is a critical parameter for rapid and sustained engraftment.
CD 34
CD34+ cell quantification is necessary to determine the optimal timing and to confirm the adequacy of Peripheral Blood Stem Cell (PBSC) harvests. This assay also helps to determine when to perform Bone marrow stem cell transplants; whether to continue Apheresis and to assess bone marrow and Cord blood viability. CD34+ absolute count is a critical parameter for rapid and sustained engraftment.
Reviews
There are no reviews yet.